Myelodysplastic Syndrome (Online)
Tracking # 20-484465
$10.00
5
(4 ratings)
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
This Intermediate to Advanced level course takes a look at Myelodysplastic Syndrome (MDS). You'll review the epidemiology, signs & symptoms, pathological and laboratory findings on peripheral smears & bone marrow, as well as treatment options and patient prognosis.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
1h
Category 1
Molecular Diagnostics Diplomate
1h
Category 1
Toxicological Chemistry Diplomate
1h
Category 1
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
1h
General (Hematology)
Clinical Laboratory Supervisor
1h
General (Hematology)
Clinical Laboratory Technician
1h
General (Hematology)
Clinical Laboratory Technologist
1h
General (Hematology)
Public Health Director
1h
General (Hematology)
Public Health Supervisor
1h
General (Hematology)
Public Health Technician
1h
General (Hematology)
Public Health Technologist
1h
General (Hematology)
Louisiana State Board of Medical Examiners - Clinical Lab Personnel
Cytotechnologist
1h
Continuing Education for Clinical Laboratory Personnel
Generalist
1h
Continuing Education for Clinical Laboratory Personnel
Specialist
1h
Continuing Education for Clinical Laboratory Personnel
Technician
1h
Continuing Education for Clinical Laboratory Personnel
Tennessee Medical Laboratory Board
Laboratory Personnel
1h
Continuing education pertaining to laboratory technology or laboratory management
Disclosure statements
At the end of this course the learner will be able to:
- Explain the epidemiology of Myelodysplastic Syndrome (MDS).
- Recall the signs and symptoms of MDS.
- Recall the pathological findings found in MDS.
- Discuss the Laboratory findings in the peripheral blood in patients with MDS
- Discuss the Laboratory findings in the bone marrow in patients with MDS.
- List the treatment options available for patients with MDS.
- Recall the prognosis for patients with MDS.